Showing results (231-240 of 1,132) with videos related to
Sort By:
Pageof 114
Journal of Hepatocellular Carcinoma|June 23, 2026
Near-Infrared Fluorescent Probes Targeting LAG-3 for Guiding Immunomodulation and Efficacy Monitoring of Stereotactic Body Radiotherapy in Liver CancerQingyun Lu, Peng Zeng, Yanli An, et al.Journal of Hepatocellular Carcinoma|June 25, 2026
Integrating Combination Therapy and Smart Embolic Materials to Overcome the Therapeutic Ceiling of Transarterial Chemoembolization in Hepatocellular CarcinomaYantao Fu, Chenglin Bai, Yunzhi Ling, et al.Journal of Hepatocellular Carcinoma|June 25, 2026
Putative Imprinting Control Regions with Aberrant Blood-Based DNA Methylation are Associated with Hepatocellular Carcinoma RiskAnnie J DiFrank, Bruce A Corliss, James J H Park, et al.Journal of Hepatocellular Carcinoma|July 6, 2026
Baseline Sleep Quality and Objective Response in HCC Patients Treated with TACE Combined with Lenvatinib and PD-1 Inhibitors: A Secondary Analysis of a Prospectively Registered Observational CohortPengfei Tian, He Zhao, Wei Sun, et al.Journal of Hepatocellular Carcinoma|September 2, 2026
The Survival Advantage of Prior Curative Hepatectomy in Patients with Hepatocellular Carcinoma Receiving First-Line Multikinase Inhibitors: A Propensity Score-Adjusted StudyJia-Min Wu, Guan-Hua Li, Cheng-Chun Lee, et al.Journal of Hepatocellular Carcinoma|August 3, 2026
PTM-Related Signatures Predict Lymph Node Metastasis and Shape Microenvironment in Hepatocellular Carcinoma: A Single-Cell and Bulk Integrated AnalysisZhu Ai, Yuying Liang, Yuzhi Cai, et al.Journal of Hepatocellular Carcinoma|August 10, 2026
Baseline ALBI Grade as an Independent Prognostic Factor of Survival in High-Risk Real-World HCC Under Atezolizumab-BevacizumabFiliz Araz, Fatih Köse, Timuçin Çil, et al.Journal of Hepatocellular Carcinoma|August 10, 2026
A Single‑Center Retrospective Cohort Study: Impact of Glycemic Control on First‑Line TKI Plus PD‑1 Inhibitors versus TKI Alone in Intermediate‑to‑advanced Unresectable Hepatocellular Carcinoma(HCC) with Type 2 Diabetes Mellitus (T2DM)Jiaqi Liu, Xiong Chen, Runxian Wang, et al.Journal of Hepatocellular Carcinoma|August 25, 2026
Multi-Target Tyrosine Kinase Inhibitors as Adjuvant Therapy for Hepatocellular Carcinoma Patients Who Achieve Complete Response After Transarterial Chemoembolization: A Real-World StudyWei Tang, Ya'nan Huang, Ting Wang, et al.Journal of Hepatocellular Carcinoma|August 26, 2026
Association of Combined Iodine-125 Seed Implantation and Atezolizumab/Bevacizumab with Improved Outcomes in Recurrent Hepatocellular Carcinoma After Hepatectomy: A Comparative Retrospective AnalysisJun Chen, Tianyou Shao, Bi ShengPageof 114